Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate

BACKGROUND: Because tenofovir alafenamide (TAF) leads to significantly lower plasma tenofovir concentrations than tenofovir disoproxil fumarate (TDF) and is a stronger substrate for P-glycoprotein (P-gp) than TDF, TAF could lead to decreased central nervous system (CNS) tenofovir exposure than TDF....

Descripción completa

Detalles Bibliográficos
Autores principales: Hermansson, Linn, Yilmaz, Aylin, Price, Richard W., Nilsson, Staffan, McCallister, Scott, Makadzange, Tariro, Das, Moupali, Zetterberg, Henrik, Blennow, Kaj, Gisslen, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905536/
https://www.ncbi.nlm.nih.gov/pubmed/31826005
http://dx.doi.org/10.1371/journal.pone.0226276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905536/
https://www.ncbi.nlm.nih.gov/pubmed/31826005
http://dx.doi.org/10.1371/journal.pone.0226276

Ejemplares similares